Exposure to vinorelbine inhibits in vitro proliferation and invasiveness of transitional cell bladder carcinoma

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 517-521

  Bonfil, R Daniel ^a   Russo, Daniela M ^a   Schmilovich, Andrés J ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Adjuvant; neoplasm invasiveness; Bladder neoplasms; chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; METALLOPROTEINASE; NAVELBINE; VINBLASTINE;

ANIMAL; ARTICLE; BLADDER TUMOR; CANCER INVASION; CELL ADHESION; CELL CULTURE; CELL DIVISION; CELL MOTION; DRUG EFFECT; PATHOLOGY; SECRETION; TRANSITIONAL CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, TRANSITIONAL CELL; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0030215632     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(01)65917-2     Document Type: Article

References (23)

1. Le Chevalier, T., Brisgand, D., Douillard, J.-Y., Pujol, J.-L., Alberola, V., Monnier, A., Riviere, A., Lianes, P., Chomy, P., Cigolari, S., Gottfried, M., Ruffie, P., Panizo, A., Gaspard, M.-H., Ravaioli, A., Besenval, M., Besson, F., Martinez, A., Berthaud, P. and Tursz, T.: Randomized study of Vinorelbine and Cisplatin versus Vindesine and Cisplatin versus Vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J. Clin. Oncol., 12: 360, 1994.
2. Potier, P.: The synthesis of Navelbine. Prototype of a new series of Vinblastine derivatives. Semin. Oncol., suppl. 4, 16:2, 1989.
3. Fair, W. R., Fuks, Z. Y. and Scher, H. I.: Cancer of the bladder. In: Cancer: Principles and Practice of Oncology. Edited by V. T. De Vita, Jr., S. Hellman and S. A. Rosenberg. Philadelphia: J. B. Lippincott Co., part 2, chapt. 34, pp. 1052-1072, 1993.
4. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D. and Boyd, M. R.: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity using human and other tumor cell lines. Cancer Res., 48: 4827, 1988.
5. Summerhayes, I. C. and Franks, L. M.: Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. J. Natl. Cancer Inst., 62: 1017, 1979.
6. Bonfil, R. D., Vinyals, A., Bustuobad, O. D., Llorens, A., Benavides, F. J., Gonzalez-Garrigues, M. and Fabra, A.: Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenicity. Int. J. Cancer, 58: 233, 1994.
7. Bonfil, R. D., Medina, P. A., Gómez, D. E., Farías, E., Lazarowski, A., Lucero Gritti, M. F., Meiss, R. P. and Bustuoabad, O. D.: Expression of gelatinase/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion. Clin. Exp. Metastasis, 10: 211, 1992.
8. Soloway, M. S.: Intravesical therapy for bladder cancer. J. Urol., 152: 379, 1994.
9. ®. Semin. Oncol., suppl. 4, 16: 15, 1989.
10. ®. Semin. Oncol., suppl. 4, 16: 21, 1989.
11. Krikorian, A. and Breillout, F.: Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid. Onkologie, 14: 7, 1991.
12. Romero, A., Rabinovich, M. G., Vallejo, C. T., Perez, J. E., Rodriguez, R., Cuevas, M. A., Machiavelli, M., Lacava, J. A., Langhi, M., Romero Acuña, L., et al.: Vinorelbine as a first-line chemotherapy for metastatic breast carcinoma. J. Clin. Oncol., 12: 336, 1994.
13. Mazzoni, A., Trave, F., Russo, P., Nicolin, A. and Rustum, Y. M.: Generation and characterization of a low-degree drug-resistant human tumor cell line. Oncology, 47: 488, 1990.
14. Liotta, L. A.: Tumor invasion and metastases. Cancer Res., 46: 1, 1986.
15. Bonfil, R. D., Reddel, R. R., Ura, H., Reich, R., Fridman, R., Harris, C. C. and Klein-Szanto, A. J. P.: Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. J. Natl. Cancer Inst., 81: 587, 1988.
16. Gilles, C., Polette, M., Piette, J., Birembaut, P. and Foidart, J.-M.: Epithelial to mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int. J. Cancer, 59: 661, 1994.
17. Ura, H., Bonfil, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C. and Klein-Szanto, A.: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res., 49: 4615, 1989.
18. Wang, M. and Stearns, M. E.: Blocking of collagenase secretion by estramustine during in vitro tumor cell invasion. Cancer Res., 48: 6262, 1988.
19. Dustin, P.: Microtubules. Sci. Am., 243: 58, 1980.
20. Mareel, M. M., Storme, G. A., Dragonetti, C. H., De-Bruyne, G. K., Hartkey-Asp, B., Segers, J. L. and Rabaey, M. L.: Anti-invasive activity of estramustine on malignant MO4 mouse cells and DU-145 human prostate carcinoma cells in vitro. Cancer Res., 48: 1842, 1988.
21. Powis, G.: Signalling targets for anticancer drug development. Trends Pharmacol. Sci., 12: 188, 1991.
22. Hait, W. and Lazzo, J.: Calmodulin: a potential target for cancer chemotherapeutic agents. J. Clin. Oncol., 4: 994, 1986.
23. Kohn, E. C. and Liotta, L. A.: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res., 55: 1856, 1995.